Main Management’s State Street SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $85K | Hold |
|
|||||
|
2025
Q1 | $84K | Sell |
|
|||||
|
2024
Q4 | $4.16M | Sell |
|
|||||
|
2024
Q3 | $6.58M | Sell |
|
|||||
|
2024
Q2 | $23.8M | Buy |
|
|||||
|
2024
Q1 | $21.3M | Buy |
|
|||||
|
2023
Q4 | $19.9M | Buy |
|
|||||
|
2023
Q3 | $16.1M | Buy |
|
|||||
|
2023
Q2 | $17.7M | Sell |
|
|||||
|
2023
Q1 | $36.2M | Buy |
|
|||||
|
2022
Q4 | $39.3M | Buy |
|
|||||
|
2022
Q3 | $29.2M | Buy |
|
|||||
|
2022
Q2 | $26.9M | Buy |
|
|||||
|
2022
Q1 | $24.8M | Buy |
|
|||||
|
2021
Q4 | $6.95M | Sell |
|
|||||
|
2021
Q3 | $8.08M | Buy |
|
|||||
|
2021
Q2 | $8.53M | Sell |
|
|||||
|
2021
Q1 | $8.65M | Sell |
|
|||||
|
2020
Q4 | $15.3M | Sell |
|
|||||
|
2020
Q3 | $12.8M | Buy |
|
|||||
|
2020
Q2 | $11.7M | Buy |
|
|||||
|
2020
Q1 | $7.67M | Sell |
|
|||||
|
2019
Q4 | $10.2M | Buy |
|
|||||
|
2019
Q3 | $7.89M | Sell |
|
|||||
|
2019
Q2 | $13.9M | Buy |
|
|||||
|
2019
Q1 | $14.2M | Buy |
|
|||||
|
2018
Q4 | $11.1M | Buy |
|
|||||
|
2018
Q3 | $14.6M | Sell |
|
|||||
|
2018
Q2 | $15.4M | Buy |
|
|||||
|
2018
Q1 | $14.1M | Buy |
|
|||||
|
2017
Q4 | $12.8M | Buy |
|
|||||
|
2017
Q3 | $12.6M | Sell |
|
|||||
|
2017
Q2 | $11.3M | Buy |
|
|||||
|
2017
Q1 | $10.1M | Buy |
|